[go: up one dir, main page]

IT1250701B - Composizione farmaceutica solida per uso orale a base di dapiprazolo - Google Patents

Composizione farmaceutica solida per uso orale a base di dapiprazolo

Info

Publication number
IT1250701B
IT1250701B ITMI912044A ITMI912044A IT1250701B IT 1250701 B IT1250701 B IT 1250701B IT MI912044 A ITMI912044 A IT MI912044A IT MI912044 A ITMI912044 A IT MI912044A IT 1250701 B IT1250701 B IT 1250701B
Authority
IT
Italy
Prior art keywords
dapiprazole
pharmaceutical composition
oral use
solid pharmaceutical
use based
Prior art date
Application number
ITMI912044A
Other languages
English (en)
Inventor
Leandro Baiocchi
Original Assignee
Angelini Francesco Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Francesco Ist Ricerca filed Critical Angelini Francesco Ist Ricerca
Publication of ITMI912044A0 publication Critical patent/ITMI912044A0/it
Priority to ITMI912044A priority Critical patent/IT1250701B/it
Priority to AT92202219T priority patent/ATE136778T1/de
Priority to DK92202219.9T priority patent/DK0524696T3/da
Priority to EP92202219A priority patent/EP0524696B1/en
Priority to DE69209916T priority patent/DE69209916T2/de
Priority to US07/917,153 priority patent/US5234927A/en
Priority to CA002074580A priority patent/CA2074580C/en
Priority to JP19827992A priority patent/JP3330977B2/ja
Publication of ITMI912044A1 publication Critical patent/ITMI912044A1/it
Priority to BG098588A priority patent/BG61242B2/bg
Application granted granted Critical
Publication of IT1250701B publication Critical patent/IT1250701B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composizione farmaceutica solida per uso orale in forma di granulato, contiene dapiprazolo o un suo sale di addizione acida fisiologicamente accettabile, almeno un eccipiente inerte farmaceuticamente accettabile ed una quantità di ossido di magnesio adatta ad arrestare o a ritardare efficacemente la degradazione del dapiprazolo o del suo sale di addizione acida.
ITMI912044A 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo IT1250701B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI912044A IT1250701B (it) 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo
DE69209916T DE69209916T2 (de) 1991-07-24 1992-07-18 Oral anzuwendende Arzneimittel Dapiprazol enthaltend
DK92202219.9T DK0524696T3 (da) 1991-07-24 1992-07-18 Orale præparater indeholdende dapiprazol
EP92202219A EP0524696B1 (en) 1991-07-24 1992-07-18 Oral compositions containing dapiprazole
AT92202219T ATE136778T1 (de) 1991-07-24 1992-07-18 Oral anzuwendende arzneimittel dapiprazol enthaltend
US07/917,153 US5234927A (en) 1991-07-24 1992-07-20 Solid pharmaceutical composition for oral administration containing dapiprazole
CA002074580A CA2074580C (en) 1991-07-24 1992-07-23 Solid pharmaceutical composition for oral administration containing dapiprazole
JP19827992A JP3330977B2 (ja) 1991-07-24 1992-07-24 ダピプラゾール含有経口投与用固体医薬組成物
BG098588A BG61242B2 (bg) 1991-07-24 1994-02-25 Твърд фармацевтичен състав за орална употреба на база дапипразол

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912044A IT1250701B (it) 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo

Publications (3)

Publication Number Publication Date
ITMI912044A0 ITMI912044A0 (it) 1991-07-24
ITMI912044A1 ITMI912044A1 (it) 1993-01-24
IT1250701B true IT1250701B (it) 1995-04-21

Family

ID=11360418

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912044A IT1250701B (it) 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo

Country Status (9)

Country Link
US (1) US5234927A (it)
EP (1) EP0524696B1 (it)
JP (1) JP3330977B2 (it)
AT (1) ATE136778T1 (it)
BG (1) BG61242B2 (it)
CA (1) CA2074580C (it)
DE (1) DE69209916T2 (it)
DK (1) DK0524696T3 (it)
IT (1) IT1250701B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (it) * 1992-07-30 1996-03-01 Pfizer
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
US6730691B1 (en) 2000-02-10 2004-05-04 Miles A. Galin Uses of alpha adrenergic blocking agents
US7147868B2 (en) * 2001-08-27 2006-12-12 Kyowa Chemical Industry Co., Ltd. Antacid and laxative tablets
US9308175B2 (en) * 2006-09-15 2016-04-12 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
US20100034888A1 (en) * 2006-09-15 2010-02-11 Hubert Clemens Pellikaan Granulate containing a pharmaceutically active substance and method for its manufacture

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1209634A (en) * 1967-06-29 1970-10-21 Rit Rech Ind Therapeut Stabilized antibiotic compositions for animal feeding and process for preparing them
IT1094076B (it) * 1978-04-18 1985-07-26 Acraf Cicloalchiltriazoli
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US4879304A (en) * 1987-05-01 1989-11-07 Angelini Pharmaceuticals Ltd. Ophthalmic compositions and process for preparing
US4879294A (en) * 1988-01-28 1989-11-07 Angelini Pharmaceuticals Ltd. Opthalmic composition
IT1224250B (it) * 1988-06-10 1990-09-26 Acraf Associzione del depiprazolo con la morfina

Also Published As

Publication number Publication date
BG61242B2 (bg) 1997-03-31
ITMI912044A1 (it) 1993-01-24
ATE136778T1 (de) 1996-05-15
CA2074580A1 (en) 1993-01-25
CA2074580C (en) 2002-12-10
DE69209916D1 (de) 1996-05-23
DE69209916T2 (de) 1996-12-05
DK0524696T3 (da) 1996-08-12
ITMI912044A0 (it) 1991-07-24
JPH05194228A (ja) 1993-08-03
EP0524696A1 (en) 1993-01-27
EP0524696B1 (en) 1996-04-17
JP3330977B2 (ja) 2002-10-07
US5234927A (en) 1993-08-10

Similar Documents

Publication Publication Date Title
ES2552639T3 (es) Uso combinado de valsartán y bloqueantes de los canales de calcio para fines terapéuticos
TW355683B (en) Composition containing micronized nebivolol
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
DE69740096D1 (de) Pharmazeutische Zusammensetzung mit einem Exendin-4-Peptid
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
ITFI930247A0 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
DK1348429T3 (da) Smelteekstruderede opioidformuleringer, der kan administreres oralt
CA2068790A1 (en) Antiviral compounds
IT8821324A0 (it) Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
DE60024491D1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
IT1301966B1 (it) Composizioni farmaceutiche ad attivita' analgesica
ITFI930030A0 (it) Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizione farmaceutiche che li contengo-no.
JP2005520779A5 (it)
CO5031291A1 (es) Composicion farmaceutica
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
IT1252692B (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
BR0112847A (pt) Uso de uma forma de dosagem sólida
IT1250701B (it) Composizione farmaceutica solida per uso orale a base di dapiprazolo
NL194390B (nl) Farmaceutische samenstelling die analgetische activiteit bezit met (s)- 2-(6-methoxy-2-naftyl)propionzuur en arginine.
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
IT1274026B (it) Composizione antitosse
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960725